Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0000905148-23-000511

Options or other derivatives

  • Chief Commercial Officer acquired 68,218 shares (grant or award)
  • Chief Commercial Officer returned 56,654 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
O'Kane Kieran Chief Commercial Officer 2021-02-23 Grant or award · Stock Options (Right to buy) +25,599 25,599 D: show line 1 in the form
O'Kane Kieran Chief Commercial Officer 2021-02-23 Grant or award · Stock Options (Right to buy) +31,055 31,055 D: show line 2 in the form
O'Kane Kieran Chief Commercial Officer 2023-07-24 Returned to the company · Stock Options (Right to buy) −25,599 0 D: show line 3 in the form
O'Kane Kieran Chief Commercial Officer 2023-07-24 Returned to the company · Stock Options (Right to buy) −31,055 0 D: show line 4 in the form
O'Kane Kieran Chief Commercial Officer 2023-07-24 Grant or award · Stock Options (Right to buy) +11,564 11,564 D: show line 5 in the form
Loading xslF345X05/form4.xml…